Statistics by Country for Guillain-Barre Syndrome
|
About these extrapolations of prevalence and incidence statistics for Guillain-Barre Syndrome:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Guillain-Barre Syndrome are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Guillain-Barre Syndrome statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Guillain-Barre Syndrome in that region.
About prevalence and incidence statistics in general for Guillain-Barre Syndrome: The word 'prevalence' of Guillain-Barre Syndrome usually means the estimated population of people who are managing Guillain-Barre Syndrome at any given time (i.e. people with Guillain-Barre Syndrome). The term 'incidence' of Guillain-Barre Syndrome means the annual diagnosis rate, or the number of new cases of Guillain-Barre Syndrome diagnosed each year (i.e. getting Guillain-Barre Syndrome). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Prevalance of Guillain-Barre Syndrome: about 1 in 100,000 (NWHIC)
Prevalance Rate for Guillain-Barre Syndrome: approx 1 in 100,000 or 0.00% or 2,720 people in USA [about data]
Extrapolation of Prevalence Rate of Guillain-Barre Syndrome to Countries and Regions: The following table attempts to extrapolate the above prevalence rate for Guillain-Barre Syndrome to the populations of various countries and regions. As discussed above, these prevalence extrapolations for Guillain-Barre Syndrome are only estimates and may have limited relevance to the actual prevalence of Guillain-Barre Syndrome in any region:
| Country/Region | Extrapolated Prevalence | Population Estimated Used |
| Guillain-Barre Syndrome in North America (Extrapolated Statistics) | ||
| USA | 2,936 | 293,655,4051 |
| Canada | 325 | 32,507,8742 |
| Guillain-Barre Syndrome in Europe (Extrapolated Statistics) | ||
| Austria | 81 | 8,174,7622 |
| Belgium | 103 | 10,348,2762 |
| Britain (United Kingdom) | 602 | 60,270,708 for UK2 |
| Czech Republic | 12 | 1,0246,1782 |
| Denmark | 54 | 5,413,3922 |
| Finland | 52 | 5,214,5122 |
| France | 604 | 60,424,2132 |
| Greece | 106 | 10,647,5292 |
| Germany | 824 | 82,424,6092 |
| Iceland | 2 | 293,9662 |
| Hungary | 100 | 10,032,3752 |
| Liechtenstein | 0 | 33,4362 |
| Ireland | 39 | 3,969,5582 |
| Italy | 580 | 58,057,4772 |
| Luxembourg | 4 | 462,6902 |
| Monaco | 0 | 32,2702 |
| Netherlands (Holland) | 163 | 16,318,1992 |
| Poland | 386 | 38,626,3492 |
| Portugal | 105 | 10,524,1452 |
| Spain | 402 | 40,280,7802 |
| Sweden | 89 | 8,986,4002 |
| Switzerland | 74 | 7,450,8672 |
| United Kingdom | 602 | 60,270,7082 |
| Wales | 29 | 2,918,0002 |
| Guillain-Barre Syndrome in the Balkans (Extrapolated Statistics) | ||
| Albania | 35 | 3,544,8082 |
| Bosnia and Herzegovina | 4 | 407,6082 |
| Croatia | 44 | 4,496,8692 |
| Macedonia | 20 | 2,040,0852 |
| Serbia and Montenegro | 108 | 10,825,9002 |
| Guillain-Barre Syndrome in Asia (Extrapolated Statistics) | ||
| Bangladesh | 1,413 | 141,340,4762 |
| Bhutan | 21 | 2,185,5692 |
| China | 12,988 | 1,298,847,6242 |
| East Timor | 10 | 1,019,2522 |
| Hong Kong s.a.r. | 68 | 6,855,1252 |
| India | 10,650 | 1,065,070,6072 |
| Indonesia | 2,384 | 238,452,9522 |
| Japan | 1,273 | 127,333,0022 |
| Laos | 60 | 6,068,1172 |
| Macau s.a.r. | 4 | 445,2862 |
| Malaysia | 235 | 23,522,4822 |
| Mongolia | 27 | 2,751,3142 |
| Philippines | 862 | 86,241,6972 |
| Papua New Guinea | 54 | 5,420,2802 |
| Vietnam | 826 | 82,662,8002 |
| Singapore | 43 | 4,353,8932 |
| Pakistan | 1,591 | 159,196,3362 |
| North Korea | 226 | 22,697,5532 |
| South Korea | 482 | 48,233,7602 |
| Sri Lanka | 199 | 19,905,1652 |
| Taiwan | 227 | 22,749,8382 |
| Thailand | 648 | 64,865,5232 |
| Guillain-Barre Syndrome in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 78 | 7,868,3852 |
| Belarus | 103 | 10,310,5202 |
| Bulgaria | 75 | 7,517,9732 |
| Estonia | 13 | 1,341,6642 |
| Georgia | 46 | 4,693,8922 |
| Kazakhstan | 151 | 15,143,7042 |
| Latvia | 23 | 2,306,3062 |
| Lithuania | 36 | 3,607,8992 |
| Romania | 223 | 22,355,5512 |
| Russia | 1,439 | 143,974,0592 |
| Slovakia | 54 | 5,423,5672 |
| Slovenia | 20 | 2,011,473 2 |
| Tajikistan | 70 | 7,011,556 2 |
| Ukraine | 477 | 47,732,0792 |
| Uzbekistan | 264 | 26,410,4162 |
| Guillain-Barre Syndrome in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 199 | 19,913,1442 |
| New Zealand | 39 | 3,993,8172 |
| Guillain-Barre Syndrome in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 285 | 28,513,6772 |
| Egypt | 761 | 76,117,4212 |
| Gaza strip | 13 | 1,324,9912 |
| Iran | 675 | 67,503,2052 |
| Iraq | 253 | 25,374,6912 |
| Israel | 61 | 6,199,0082 |
| Jordan | 56 | 5,611,2022 |
| Kuwait | 22 | 2,257,5492 |
| Lebanon | 37 | 3,777,2182 |
| Libya | 56 | 5,631,5852 |
| Saudi Arabia | 257 | 25,795,9382 |
| Syria | 180 | 18,016,8742 |
| Turkey | 688 | 68,893,9182 |
| United Arab Emirates | 25 | 2,523,9152 |
| West Bank | 23 | 2,311,2042 |
| Yemen | 200 | 20,024,8672 |
| Guillain-Barre Syndrome in South America (Extrapolated Statistics) | ||
| Belize | 2 | 272,9452 |
| Brazil | 1,841 | 184,101,1092 |
| Chile | 158 | 15,823,9572 |
| Colombia | 423 | 42,310,7752 |
| Guatemala | 142 | 14,280,5962 |
| Mexico | 1,049 | 104,959,5942 |
| Nicaragua | 53 | 5,359,7592 |
| Paraguay | 61 | 6,191,3682 |
| Peru | 275 | 27,544,3052 |
| Puerto Rico | 38 | 3,897,9602 |
| Venezuela | 250 | 25,017,3872 |
| Guillain-Barre Syndrome in Africa (Extrapolated Statistics) | ||
| Angola | 109 | 10,978,5522 |
| Botswana | 16 | 1,639,2312 |
| Central African Republic | 37 | 3,742,4822 |
| Chad | 95 | 9,538,5442 |
| Congo Brazzaville | 29 | 2,998,0402 |
| Congo kinshasa | 583 | 58,317,0302 |
| Ethiopia | 713 | 71,336,5712 |
| Ghana | 207 | 20,757,0322 |
| Kenya | 329 | 32,982,1092 |
| Liberia | 33 | 3,390,6352 |
| Niger | 113 | 11,360,5382 |
| Nigeria | 177 | 12,5750,3562 |
| Rwanda | 82 | 8,238,6732 |
| Senegal | 108 | 10,852,1472 |
| Sierra leone | 58 | 5,883,8892 |
| Somalia | 83 | 8,304,6012 |
| Sudan | 391 | 39,148,1622 |
| South Africa | 444 | 44,448,4702 |
| Swaziland | 11 | 1,169,2412 |
| Tanzania | 360 | 36,070,7992 |
| Uganda | 263 | 26,390,2582 |
| Zambia | 110 | 11,025,6902 |
| Zimbabwe | 36 | 1,2671,8602 |
Incidence (annual) of Guillain-Barre Syndrome: about 1 in 100,000 (NWHIC)
Incidence Rate for Guillain-Barre Syndrome: approx 1 in 100,000 or 0.00% or 2,720 people in USA [about data]
Extrapolation of Incidence Rate for Guillain-Barre Syndrome to Countries and Regions: The following table attempts to extrapolate the above incidence rate for Guillain-Barre Syndrome to the populations of various countries and regions. As discussed above, these incidence extrapolations for Guillain-Barre Syndrome are only estimates and may have limited relevance to the actual incidence of Guillain-Barre Syndrome in any region:
| Country/Region | Extrapolated Incidence | Population Estimated Used |
| Guillain-Barre Syndrome in North America (Extrapolated Statistics) | ||
| USA | 2,936 | 293,655,4051 |
| Canada | 325 | 32,507,8742 |
| Guillain-Barre Syndrome in Europe (Extrapolated Statistics) | ||
| Austria | 81 | 8,174,7622 |
| Belgium | 103 | 10,348,2762 |
| Britain (United Kingdom) | 602 | 60,270,708 for UK2 |
| Czech Republic | 12 | 1,0246,1782 |
| Denmark | 54 | 5,413,3922 |
| Finland | 52 | 5,214,5122 |
| France | 604 | 60,424,2132 |
| Greece | 106 | 10,647,5292 |
| Germany | 824 | 82,424,6092 |
| Iceland | 2 | 293,9662 |
| Hungary | 100 | 10,032,3752 |
| Liechtenstein | 0 | 33,4362 |
| Ireland | 39 | 3,969,5582 |
| Italy | 580 | 58,057,4772 |
| Luxembourg | 4 | 462,6902 |
| Monaco | 0 | 32,2702 |
| Netherlands (Holland) | 163 | 16,318,1992 |
| Poland | 386 | 38,626,3492 |
| Portugal | 105 | 10,524,1452 |
| Spain | 402 | 40,280,7802 |
| Sweden | 89 | 8,986,4002 |
| Switzerland | 74 | 7,450,8672 |
| United Kingdom | 602 | 60,270,7082 |
| Wales | 29 | 2,918,0002 |
| Guillain-Barre Syndrome in the Balkans (Extrapolated Statistics) | ||
| Albania | 35 | 3,544,8082 |
| Bosnia and Herzegovina | 4 | 407,6082 |
| Croatia | 44 | 4,496,8692 |
| Macedonia | 20 | 2,040,0852 |
| Serbia and Montenegro | 108 | 10,825,9002 |
| Guillain-Barre Syndrome in Asia (Extrapolated Statistics) | ||
| Bangladesh | 1,413 | 141,340,4762 |
| Bhutan | 21 | 2,185,5692 |
| China | 12,988 | 1,298,847,6242 |
| East Timor | 10 | 1,019,2522 |
| Hong Kong s.a.r. | 68 | 6,855,1252 |
| India | 10,650 | 1,065,070,6072 |
| Indonesia | 2,384 | 238,452,9522 |
| Japan | 1,273 | 127,333,0022 |
| Laos | 60 | 6,068,1172 |
| Macau s.a.r. | 4 | 445,2862 |
| Malaysia | 235 | 23,522,4822 |
| Mongolia | 27 | 2,751,3142 |
| Philippines | 862 | 86,241,6972 |
| Papua New Guinea | 54 | 5,420,2802 |
| Vietnam | 826 | 82,662,8002 |
| Singapore | 43 | 4,353,8932 |
| Pakistan | 1,591 | 159,196,3362 |
| North Korea | 226 | 22,697,5532 |
| South Korea | 482 | 48,233,7602 |
| Sri Lanka | 199 | 19,905,1652 |
| Taiwan | 227 | 22,749,8382 |
| Thailand | 648 | 64,865,5232 |
| Guillain-Barre Syndrome in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 78 | 7,868,3852 |
| Belarus | 103 | 10,310,5202 |
| Bulgaria | 75 | 7,517,9732 |
| Estonia | 13 | 1,341,6642 |
| Georgia | 46 | 4,693,8922 |
| Kazakhstan | 151 | 15,143,7042 |
| Latvia | 23 | 2,306,3062 |
| Lithuania | 36 | 3,607,8992 |
| Romania | 223 | 22,355,5512 |
| Russia | 1,439 | 143,974,0592 |
| Slovakia | 54 | 5,423,5672 |
| Slovenia | 20 | 2,011,473 2 |
| Tajikistan | 70 | 7,011,556 2 |
| Ukraine | 477 | 47,732,0792 |
| Uzbekistan | 264 | 26,410,4162 |
| Guillain-Barre Syndrome in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 199 | 19,913,1442 |
| New Zealand | 39 | 3,993,8172 |
| Guillain-Barre Syndrome in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 285 | 28,513,6772 |
| Egypt | 761 | 76,117,4212 |
| Gaza strip | 13 | 1,324,9912 |
| Iran | 675 | 67,503,2052 |
| Iraq | 253 | 25,374,6912 |
| Israel | 61 | 6,199,0082 |
| Jordan | 56 | 5,611,2022 |
| Kuwait | 22 | 2,257,5492 |
| Lebanon | 37 | 3,777,2182 |
| Libya | 56 | 5,631,5852 |
| Saudi Arabia | 257 | 25,795,9382 |
| Syria | 180 | 18,016,8742 |
| Turkey | 688 | 68,893,9182 |
| United Arab Emirates | 25 | 2,523,9152 |
| West Bank | 23 | 2,311,2042 |
| Yemen | 200 | 20,024,8672 |
| Guillain-Barre Syndrome in South America (Extrapolated Statistics) | ||
| Belize | 2 | 272,9452 |
| Brazil | 1,841 | 184,101,1092 |
| Chile | 158 | 15,823,9572 |
| Colombia | 423 | 42,310,7752 |
| Guatemala | 142 | 14,280,5962 |
| Mexico | 1,049 | 104,959,5942 |
| Nicaragua | 53 | 5,359,7592 |
| Paraguay | 61 | 6,191,3682 |
| Peru | 275 | 27,544,3052 |
| Puerto Rico | 38 | 3,897,9602 |
| Venezuela | 250 | 25,017,3872 |
| Guillain-Barre Syndrome in Africa (Extrapolated Statistics) | ||
| Angola | 109 | 10,978,5522 |
| Botswana | 16 | 1,639,2312 |
| Central African Republic | 37 | 3,742,4822 |
| Chad | 95 | 9,538,5442 |
| Congo Brazzaville | 29 | 2,998,0402 |
| Congo kinshasa | 583 | 58,317,0302 |
| Ethiopia | 713 | 71,336,5712 |
| Ghana | 207 | 20,757,0322 |
| Kenya | 329 | 32,982,1092 |
| Liberia | 33 | 3,390,6352 |
| Niger | 113 | 11,360,5382 |
| Nigeria | 177 | 12,5750,3562 |
| Rwanda | 82 | 8,238,6732 |
| Senegal | 108 | 10,852,1472 |
| Sierra leone | 58 | 5,883,8892 |
| Somalia | 83 | 8,304,6012 |
| Sudan | 391 | 39,148,1622 |
| South Africa | 444 | 44,448,4702 |
| Swaziland | 11 | 1,169,2412 |
| Tanzania | 360 | 36,070,7992 |
| Uganda | 263 | 26,390,2582 |
| Zambia | 110 | 11,025,6902 |
| Zimbabwe | 36 | 1,2671,8602 |
Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
Last revision: May 28, 2003
Medical Tools & Articles:
Next articles:
Medical Articles: